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Colon cancer remains as a serious health problem around the world despite advances in
diagnosis and treatment. Dietary fibers are considered to reduce the risk of colon cancer as
they are converted to short chain fatty acids by the presence of anaerobic bacteria in the
intestine, but imbalanced diet and high fat consumption may promote tumor formation at
different sites, including the large bowel via increased bacterial enzymes activity. The
present study was conducted to characterize the inhibitory action of myrtenal on bacterial
enzymes and aberrant crypt foci (ACF). Experimental colon carcinogenesis induced by 1,2-
dimethylhydrazine is histologically, morphologically, and anatomically similar to human
colonic epithelial neoplasm. Discrete microscopic mucosal lesions such as ACF and ma-
lignant tumors function as important biomarkers in the diagnosis of colon cancer. Meth-
ylene blue staining was carried out to visualize the impact of 1,2-dimethylhydrazine and
myrtenal. Myrtenal-treated animals showed decreased levels of bacterial enzymes such as
b-glucuronidase, b-glucosidase, and mucinase. Characteristic changes in the colon were
noticed by inhibiting ACF formation in the colon. In conclusion, treatment with myrtenalacology and Environmental Toxicology, Dr. A.L. Mudhaliar Post Graduate Institute of Basic
mani Campus, Chennai 600 113, Tamil Nadu, India.
m (B. Maruthaiveeran Periyasamy).
inistration, Taiwan. Published by Elsevier Taiwan LLC. This is an open access article under the CC
/licenses/by-nc-nd/4.0/).
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dence of decreased crypt multiplicity and tumor progression.
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Colorectal cancer is a major cause of death in developed
countries with an increased rate of morbidity and mortality
[1]. The incidence rate continues to rise as people change their
lifestyles and food habits [2]. In this regard, substance-use
disorders are associated with numerous medical, psychiat-
ric, psychological, spiritual, economic, social, family, and legal
problems, creating a significant burden for affected in-
dividuals, their families, and society [3]. Insidious factors such
as alcohol, smoking, sedentary lifestyle, aging, and diet are the
most important exogenous promoters of colon cancer [4].
Supporting this, Chang [5] investigated the mechanisms by
which alcohol damages immune defense function to identify
therapeutic targets for effective treatment of alcoholic pa-
tients with severe bacterial infection. Davie [6] stated that
dietary fibers are considered to reduce the risk of colon cancer
as they are converted to short chain fatty acids by the pres-
ence of anaerobic bacteria in the intestine, which prevents the
invasion of pathogenic bacteria [7]. However, imbalanced diet
and high fat consumption is known to alter this protective
metabolism of the intestinal microflora, and reduce the host
immune response by increased bacterial enzyme activity [8].
Thereby b-glucuronidase activity in the intestine plays a
major role in the generation of toxic and carcinogenic me-
tabolites thatmay promote tumor formation at different sites,
including the large bowel [9]. In that way, 1,2-
dimethylhydrazine (DMH), a procarcinogen, is metabolized
by b-glucuronidase enzymes along with its metabolic
pathway in the liver and released as a carcinogen in the colon
epithelium to induce colon cancer in experimental animals
[10]. A variety of fungi and bacteria synthesize the major
component enzyme, b-glucosidase, which can synergistically
convert cellulose into glucose for the enzymatic depolymer-
ization of cellulosic material [11]. Enzymatic hydrolysis of
cellulose is a major limitation in lignocellulose's conversion to
glucose, as b-glucosidase activity causes accumulation of
aglycones [12]. Robertson et al [13] proved that hydrolytic ac-
tivity of the bacterial enzyme mucinase acts on the destruc-
tion of mucins or their prosthetic polysaccharides by the
bacteria. The intestinal mucinous layer also experiences an
autolytic enzyme hydrolysis, leading to altered permeability
of the mucosal membrane. Nitroreductase is involved in the
reduction of nitrogen-containing compounds including nitro
functional group members such as dinitrotoluene, nitroben-
zenes, and nitropyrenes to amines. A number of these pro-
teins are described as oxidoreductases and are primarily
found in bacterial lineages that exhibit toxic, mutagenic or
carcinogenic activities [14,15].
Colon cancer has been postulated as a complex and
multistage process that includes a series of pathologicalalterations ranging from discrete microscopic mucosal le-
sions, such as aberrant crypt foci (ACF), to malignant tumors
[16]. ACF are generally considered the earliest identifiable
macroscopic lesion within the colonic mucosa that may be
associated with risk of future neoplastic development [17].
Due to morphological and genetic similarities in ACF devel-
opment between rodents and humans, this preneoplastic
lesion may be used in cancer screening and prevention
studies for the detection of risk factors and protective factors
associated with colon cancer progression [18]. Among various
biomarkers, ACF and mucin-depleted foci are recognized on
the surface of cancer-predisposed colons of rodents and
humans [19]. Therefore, an experimental model of colon
cancer was induced with DMH, a chemical carcinogen known
to cause colon cancer with a reproducible experimental in vivo
system for studying sporadic forms of colon carcinoma [20].
Colon carcinogenesis induced by DMH is histologically,
morphologically, and anatomically similar to human colonic
epithelial neoplasms with ACF, as one of the early morpho-
logical changes on the DMH-stimulated colonic mucosal sur-
face in rodents [21], containing crypts that are larger in
diameter and stain deeper with methylene blue than normal
crypts, are considered as a reliable surrogate biomarker of
colorectal cancer. Hence chemoprevention trials with colo-
rectal ACF set as the primary endpoint may have some ad-
vantages [22].
Monoterpenes found in the essential oils of numerous
species of plants including mints, cherries, and celery seeds
have shown chemopreventive and therapeutic activity in ro-
dent colon tumor models [23]. They are nonnutritive dietary
components found in the essential oils of citrus fruits and
other plants. A number of these dietary monoterpenes have
antitumor activity. For example, d-limonene, which com-
prises > 90% of orange peel oil, has chemopreventive activity
against rodent mammary, skin, liver, lung, and forestomach
cancers. Similarly, other dietary monoterpenes have chemo-
preventive activity against rat mammary, lung, and forest-
omach cancers when fed during the initiation phase. The
monoterpenes have several cellular and molecular activities
that could potentially underlie their positive therapeutic
index. Among naturally occurring oxygen-containing mono-
terpene derivatives, myrtenal is one of the most widespread
compounds distributed in the Asteraceae family. It is a ubiq-
uitous constituent of the essential oils of flowers, stems, and
leaves that possess antimicrobial and antifungal activities
[24]. Biological interest on the isoprenoid structure of myrte-
nal was found to suppress the proliferation of carcinogenic
processes [25]. Wattenberg et al [26] explained the action of
chemopreventive agents during the initiation phase of carci-
nogenesis to prevent the interaction of chemical carcinogens
with DNA, by modulating carcinogenmetabolism to less toxic
forms to prevent the outgrowth of initiated cells. Thus,
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nisms in the chemoprevention and chemotherapy of colon
cancer. In particular, the specific mechanism of mono-
terpenes inhibit the post translational isoprenylation of cell
growth-regulatory proteins such as Ras that could alter signal
transduction and result in altered gene expression leading to
downregulation of proliferating cancer cells.2. Methods
2.1. Reagents
DMH and myrtenal were purchased from Sigma Chemical
Company (St. Louis, MO, USA). All the other chemicals used in
this study were of analytical grade available commercially.
2.2. Experimental animals
Experiments were carried out with 5 week old male Wistar
rats procured from central animal house facility, Dr. A.L.M.
Postgraduate Institute of Basic Medical Sciences, University of
Madras, Taramani, Chennai, India. They were maintained in
the controlled environmental conditions of temperature and
humidity on alternative 12-hour lightedark cycle, noise level
maintained below 85 dB, and had unrestricted access to
standard diet consisting of 24% protein, 4.5% fat, and 4% fiber.
The experiment was sanctioned and approved by the Insti-
tutional Animal Ethical Committee (IAEC No.01/13/2013).
2.3. Experimental design
The experimental animals were divided into four groups, each
group with six animals. Group 1: Control animals fed with
standard diet and pure drinking water. Group 2: Animals were
administered with 20 mg/kg body weight of DMH, in 1mM
EDTA, pH adjusted to 6.5with 1mMNaOH and subcutaneously
injected once a week for 15 weeks. Group 3: Animals were
treatedwithmyrtenal (230mg/kg bodyweight) with corn oil as
vehicle for 30 weeks by intragastric administration. Myrtenal
treatment was started 1 week prior to the first dose of 20 mg/
kg body weight of DMH (as in Group 2) and continued till end
of the experimental period. Group 4: Animals were treated
with myrtenal (230 mg/kg body weight) for 30 weeks by
intragastric administration to assess the cytotoxicity if any,
induced by myrtenal, and rats were referred as drug control.
After the end of the experimental period, the rats were
fasted overnight and anesthetized using diethyl ether and
sacrificed by cervical decapitation. A portion of colon was
used for histopathological studies and remaining tissue was
homogenized in 0.1M TriseHCl buffer pH 7.4 and centrifuged;
the supernatant was used for biochemical studies.
2.4. Colon analysis
Colons were excised from experimental rats, and were blotted
dry and opened longitudinally, with the inner surface exam-
ined for visible macroscopic lesions. Tumor incidence (per-
centage of animals with tumors) and multiplicity (mean
counted tumors per animals) were determined for the colons.Immediately following sacrifice, colons were removed and
washed with ice-cold saline, and colon homogenates (10%)
were prepared in ice cold TBS (50mMTris and 150mMNaCl; pH
7.2) then centrifuged at 10,000g for 10minutes at 4C and were
stored as aliquots at or below 20C for subsequent assays.
2.5. Identification of ACF
The colon was detached, flushed with 0.9% saline, opened
from cecum to anus, divided into three segments and fixed flat
between two pieces of filter paper in 10% buffered formalin.
Microscopic slides were placed on top of the filter paper to
ensure that the tissue remained flat during fixation. After 24
hours in buffered formalin, the colon was stained with 0.2%
methylene blue as described by Bird and Good [27]. It was then
placed mucosal side up, again on a microscopic slide and
observed under a light microscope. Aberrant crypts were
distinguished from the surrounding normal crypts by their
increased size, significantly increased distance from laminae
to basal surface of cells, and the easily discernible pericryptal
zone. Crypt multiplicity was determined as the number of
crypts in each focus and was categorized as containing one,
two, three, four, or more aberrant crypts/focus.
2.6. Measurement of bacterial enzyme activity
The colon was flushed gently with saline, cut open longitu-
dinally, and placed on a flat surface. Mucosal samples were
collected by gently scraping the colonic mucosal layer using
microscopic slides. The collected samples were transferred
into preweighed tubes containing 0.1M phosphate-buffered
saline (pH 7.0) and sonicated for 30 seconds. Fecal and
mucosal sampleswere centrifuged at 2000g for 5minutes, and
aliquots of supernatant were used immediately.
Beta-glucuronidase activity was measured by the method
of Freeman [28] (1986). It consists of supernatant enzymewith
0.02M phosphate buffer adjusted to pH 7.0, 0.1mM EDTA, and
3.0mM p-nitrophenyl-b-D-glucopyranoside. The mixture was
incubated at 37C for 20 minutes. The reaction was arrested
with 0.2M glycine buffer (pH 10.4) and the amount of p-
nitrophenol released was read at 540 nm with a spectropho-
tometer. All reactions were linear with respect to concentra-
tion and incubation time to 45 minutes. The amount of p-
nitrophenol liberated was determined by comparison with a
standard nitrophenol curve.
Beta-glucosidase activity was measured by the method of
Freeman [28]. The mixture of samples and substrate (p-
nitrophenyl-b-D-glucoside) were incubated with 37C for 60
minutes. After incubation, 0.2M Na2CO3, was added to arrest
the reaction. The released p-nitrophenol was measured at
400 nm. All reactions were linear with respect to concentra-
tion and incubation time to 60 minutes. The amount of p-
nitrophenol liberated was determined by comparison with a
standard nitrophenol curve.
Beta-galactosidase activity wasmeasured by themethod of
Freeman [28]. The mixture contained 3mM p-nitrophenyl-b-
D-galactopyranoside, a known volume of sample and incu-
bated at 37C for 15 minutes. Then the reaction was termi-
nated by the addition of 0.25M Na2CO3. Release of p-
nitrophenol was measured spectrophotometrically at 405 nm.
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comparison with a standard nitrophenol curve.
Mucinase activity was determined by the method of Shiau
and Chang [29]. The assay mixture contained 0.2M porcine
gastricmucinwith a known amount of fecal suspensionmade
up to 1 mL with distilled water. The mixture was then incu-
bated at 37C for 25 minutes. The amount of reducing sugar
was measured by the method of Nelson [30] at 520 nm. Values
are expressed as mg of glucose liberated/min/mg protein.
Nitroreductase activity was measured by the method of
Bratton and Marshall [31]. The assay mixture contained
1.5mM p-nitrobenzoic acid, 0.1M of phosphate buffer, and a
known amount of sample. The reaction was arrested by the
addition of 20% trichloroacetic acid and centrifuged. P-ami-
nobenzoic acid released was measured at 550 nm. The
amount of transformed substrate was determined by com-
parison with a standard curve.
Sulfatase activity wasmeasured by themethod of Rowland
et al [32]. The reaction mixture contained 0.02M phosphate
buffered saline, 1mM EDTA, 1mM p-nitrocatechol sulfate, and
a known amount of enzyme suspension. The reaction was
arrested with 0.01M NaOH, and the amount of p-nitrocatechol
liberated was read spectrophotometrically at 492 nm. All the
reactions were linear with respect to concentration and in-
cubation time to 60 minutes. Protein content of fecal and
mucosal samples was measured by the method of Lowry et al
[33].
2.7. Statistical analysis
Values are expressed as mean ± standard deviation. The re-
sults were statistically evaluated using one-way analysis of
variance (ANOVA) by SPSS student version 10.0 (SPSS, Chi-
cago, IL, USA), followed by Tukey's multiple comparison
method to compare means of different groups. The mean
difference is significant at the 0.05 levels.3. Results
3.1. Colon tumor analysis: Tumor incidence
Tables 1 and 2 depict the DMH-induced colon tumor devel-
opment and crypt multiplicity respectively. DMH-induced
Group 2 rats exhibited 100% tumor development throughout
the colon. Myrtenal treatment in Group 3 resulted in the
decrease of tumor incidence percentage. Similarly, in Table 2,
crypt multiplicity results show that Group 2 rats had more
crypts ranging from one, two, three, and four crypts in theTable 1 e Effect of myrtenal on 1,2-dimethyl hydrazine induce
Groups No. of rats No. of tumor-bearing
rats in
1 6 0
2 6 6
3 6 1
4 6 0
a (Number of tumor bearing rats/total number of rats in each group)  1DMH-induced group. Crypt multiplicity was controlled and
seen to be reduced inmyrtenal-treated Group 3 rats compared
to Group 2. Control and myrtenal alone-treated groups
showed no significant difference.
3.2. Effect of myrtenal on bacterial enzymes
Figs. 1 and 2 show the activity of fecal and mucosal bio-
transforming enzyme activity of control and experimental
rats. The DMH-treated rats in Group 2 showed increased
bacterial enzyme activity compared to control, whereas the
activities of the bacterial enzymes were found to revert back
to near normal upon myrtenal administration in Group 3 rats
compared to Group 2 DMH-induced colon cancer rats.
3.3. Effect of myrtenal and the assessment of ACF
Methylene blue staining (Fig. 3) shows the formation of
crypts in DMH-treated Group 2 rats with normal structure in
Group 1 control animals. The intensity of staining was found
to decrease in myrtenal-supplemented rats in Group 3 when
compared with Group 2 animals. Normal structure was iden-
tified in Group 4 myrtenal alone-treated rats.4. Discussion
Monoterpenes have shown chemopreventive and therapeutic
activity in colon tumor models and also in clinical studies on
cancer patients [34]. Several patients with refractory colon
cancer andmetastatic colorectal cancer have shown evidence
of its antitumor activity [34]. In addition, monoterpenes have
been shown to inhibit both the growth of tumors and the post-
translational isoprenylation of cellular proteins, including ras
[35]. Intense research on nitrilimine cycloaddition with
monoterpenes, such as myrtenal, produced 4,5-
dihydropyrazole-containing skeletons of biological interest,
as the mentioned isoprenoids can suppress the proliferation
of cancer cells [36]. Dietary supplementation of myrtenal is
thought to reduce colon cancer, since the colon is considered
to have bacterial enzymes which transforms the xenobiotic
substances to direct-acting genotoxins [37] and detoxification
products formed in the liver are reactivated in the gut by
bacterial enzymes [38]. Similar to the activation of DMH in the
liver followed by intestinal bacterial enzymes to produce
carcinogenic effect on the colon epithelium reported by Reddy
et al [39].
Secondary bile acids produced from bacterial actions in the
colon undergoes glucuronidation, which is involved ind tumor incidence percentage.a
Tumor
cidence (%)a
Total No. of
tumors
No. of tumors/tumor
bearing rats
0 0 0
100 20 3.33
16.66 2 2.0
0 0 0
00.
Table 2 e Effect of myrtenal on 1,2-dimethyl hydrazine induced aberrant crypt foci (ACF) formation in rats.a
Experimental groups Total No. of ACF/colon 1 crypt 2 crypts 3 crypts 4 crypts
1 0 0 0 0 0
2 56 ± 3.35 12 ± 0.98 18 ± 0.81 16 ± 0.81 10 ± 0.75
3 30 ± 3.06* 7 ± 0.63* 8 ± 0.54* 9 ± 0.89* 6. ± 1.0*
4 0 0 0 0 0
Values are represented as mean ± standard deviation for six rats in each group.
*denotes the significant difference between the major two groups.
a p < 0.05 compared to 1,2-dimethyl hydrazine treated group. Number of total ACF and ACF with one, two, three, and four crypts/focus at the
end of the experiment.
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ronidase that catalyzes hydrolysis of b-glucuronic acid and
liberates unconjugated chemical carcinogens on the walls of
the colon epithelium [40]. Increased b-glucuronidase activity
noticed in DMH treated rats shows the metabolic degradation
of the carcinogens. At this juncture, the b-glucuronidase ac-
tivity was found decreased upon myrtenal treatment which
may due to the anti-inflammatory property of myrtenal.
Cytosolic b-glucosidase functions in major metabolic path-
ways that occur in the cytosol in animals such as glycolysis
and gluconeogenesis, but it is predominantly found in liver,
kidney, and intestine, and efficiently hydrolyzes b-D-gluco-
side [41]. It is also involved in the hydrolysis of plant glyco-
sides to produce agylocones that could be carcinogenic upon
its increased activity as in the case of DMH-treated rats. The
supplementation of myrtenal has been found to decrease its
activity, which may be due to its protective role against colon
cancer via its inhibitory action against b-glucosidase.
Beta-galactosidase is a lysosomal exoglycosidase involved
in the catabolism of glycoconjugates by sequential release ofFig. 1 e Effect of 1,2-dimethyl hydrazine and myrtenal treatmen
expressed as mean ± standard deviation for six animals. a Grou
with Group 2. *p < 0.05. Units: b-glucuronidase, b-galactosidase
glucosidase ¼ mg of p-nitrophenol liberated/min/g protein; Mu
Nitroreductase ¼ mmol of p-aminobenzoic liberated/min/g prote
protein. ns ¼ not significant.b-linked terminal galactosyl residues which degrade peri-
cancerous matrix favoring tumor growth, invasion, and met-
astatic propagation in the intestine [42]. The elevated b-
galactosidase levels were brought back to near normal in
myrtenal-treated rats as the tumors completely regressed.
Increased mucus shedding by an enzyme capable of destroy-
ing mucin, with contribution from multiple enzymes is an
important factor elaborating the degradation of mucosal layer
on the intestinal layer and represents a potential target on the
colon epithelium which permits measurement of mucin
degradation by release of reducing sugars [43]. Myrtenal
treatment was found to reduce the enzyme mucinase by
decreasing colonic mucosal cell microsomal enzyme activity
that plays a role in the metabolism of many drugs by inhib-
iting the transformation of precarcinogens into colon carcin-
ogens [44].
A wealth of evidence supports that cell transformation and
evolution through the different stages of malignancy is
accompanied by modifications in sulfate expression and
structure including changes in 6-O-sulfation [45]. Increasedt on fecal biotransforming enzymes in rats. Results are
ps 2, 3, and 4 compared with Group 1. b Group 3 compared
¼ mg of p-nitrophenol liberated/min/g protein; b-
cinase ¼ mg of glucose liberated/min/mg protein;
in; Sulfatase ¼ mmol of p-nitrocatechol liberated/min/g
Fig. 2 e Effect of 1,2-dimethyl hydrazine and myrtenal treatment on mucosal biotransforming enzymes in rats. Results are
expressed as mean ± standard deviation for six animals. a Groups 2, 3, and 4 compared with Group 1. b Group 3 compared
with Group 2. *p < 0.05, ns¼ not significant. Units: b-glucuronidase, b-galactosidase¼mg of p-nitrophenol liberated/min/g
protein; b-glucosidase ¼mg of p-nitrophenol liberated/min/g protein; Nitroreductase ¼ mmol of p-aminobenzoic liberated/
min/g protein.
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treated groups due to the bacterial lineages, but myrtenal
supplementation reduced the activity of sulfatase and nitro-
reductase, which may be due to the tumor-suppressing ac-
tivity through inhibition of pro-oncogenic growth factors. In
conclusion, the increased activity of bacterial enzymes by
DMH-induced groups failed to proceed as myrtenal playsFig. 3 e Aberrant crypt foci analysis by methylene blue staining
normal epithelial lining. (B) 1,2-dimethyl hydrazine induced cryp
staining of methylene blue. (C) 1,2-dimethyl hydrazine þ myrte
with few crypts to normal architecture. (D) Myrtenal alone withsome key role in interrupting the energy requirement of
tumor tissues and leads to the suppression of tumor growth
and producing inhibitory mechanism against enhanced bac-
terial activity in the intestine.
ACF are benign adenomatous polyps that progress into an
advanced adenoma with high-grade dysplasia that later can
lead to an invasive cancer [46]. ACF refer to the abnormalin control and experimental animals. (A) Control with
ts with elongated lamellae andmultiple crypts with deeper
nal treated group with transformation of the cancer cells
normal morphology.
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and foci with several or multiple mutations gathered together
in a focal distribution are characteristics of ACF [47]. In both
rodents and humans, the pathogenesis of colorectal cancer
induced by carcinogens produces ACF, the precancerous le-
sions of colorectal cancer, which are considered to be good
biological markers for evaluating the effect of drugs that are
used to prevent and control the formation of colorectal cancer
in rats [48]. ACF analysis done according to the method
described by Bird [49] produced results with increased size, a
significantly increased distance from the lamina to the basal
surface of the cells, darker stain, and importantly four ormore
aberrant crypts/foci were categorized as multicrypts. The in-
creases in ACF count and number of polyps were used to
evaluate the extent of damage to the colon caused by DMH
[50]. Myrtenal supplementation has been shown to decrease
the number of crypts multiplicity and improved morpholog-
ical and structural changes, along with few dysplastic colo-
nocytes, and congested sinusoids. As reported by Karthik
Kumar et al [51], the decrease in the level of b-glucuronidase
activity in the colonmay be directly linked with the formation
of colonic crypts relating a correlation with b-glucuronidase
and crypt multiplicity. In our study the myrtenal-treated an-
imals showed no characteristic change in the colon, which
clearly indicates the anticancer activity of myrtenal against
DMH-induced colon cancer in Wistar rats.Conflicts of interest
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